Ten years of anti-vascular endothelial growth factor therapy
N Ferrara, AP Adamis - Nature reviews Drug discovery, 2016 - nature.com
The targeting of vascular endothelial growth factor A (VEGFA), a crucial regulator of both
normal and pathological angiogenesis, has revealed innovative therapeutic approaches in …
normal and pathological angiogenesis, has revealed innovative therapeutic approaches in …
Molecular pathogenesis of retinal and choroidal vascular diseases
PA Campochiaro - Progress in retinal and eye research, 2015 - Elsevier
There are two major types of ocular neovascularization that affect the retina, retinal
neovascularization (NV) and subretinal or choroidal NV. Retinal NV occurs in a group of …
neovascularization (NV) and subretinal or choroidal NV. Retinal NV occurs in a group of …
Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions
I Klaassen, CJF Van Noorden… - Progress in retinal and …, 2013 - Elsevier
Breakdown of the inner endothelial blood-retinal barrier (BRB), as occurs in diabetic
retinopathy, age-related macular degeneration, retinal vein occlusions, uveitis and other …
retinopathy, age-related macular degeneration, retinal vein occlusions, uveitis and other …
Mechanisms and management of retinopathy of prematurity
Mechanisms and Management of Retinopathy of Prematurity | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search …
Skip to main content The New England Journal of Medicine homepage Advanced Search …
The biology of VEGF and its receptors
N Ferrara, HP Gerber, J LeCouter - Nature medicine, 2003 - nature.com
Vascular endothelial growth factor (VEGF) is a key regulator of physiological angiogenesis
during embryogenesis, skeletal growth and reproductive functions. VEGF has also been …
during embryogenesis, skeletal growth and reproductive functions. VEGF has also been …
[PDF][PDF] Microvascular and macrovascular complications of diabetes
MJ Fowler - Clinical diabetes, 2008 - cmbdiabetes.wdfiles.com
Diabetes is a group of chronic diseases characterized by hyperglycemia. Modern medical
care uses a vast array of lifestyle and pharmaceutical interventions aimed at preventing and …
care uses a vast array of lifestyle and pharmaceutical interventions aimed at preventing and …
The biology of vascular endothelial growth factor
N Ferrara, T Davis-Smyth - Endocrine reviews, 1997 - academic.oup.com
Biology of Vascular Endothelial Growth Factor | Endocrine Reviews | Oxford Academic Skip to
Main Content Advertisement Oxford Academic Journals Books Search Menu Information …
Main Content Advertisement Oxford Academic Journals Books Search Menu Information …
Anti‐vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity
Background Vascular endothelial growth factor (VEGF) plays a key role in angiogenesis in
foetal life. Researchers have recently attempted to use anti‐VEGF agents for the treatment of …
foetal life. Researchers have recently attempted to use anti‐VEGF agents for the treatment of …
Vascular endothelial growth factor: basic science and clinical progress
N Ferrara - Endocrine reviews, 2004 - academic.oup.com
Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen in vitro and
an angiogenic inducer in a variety of in vivo models. Hypoxia has been shown to be a major …
an angiogenic inducer in a variety of in vivo models. Hypoxia has been shown to be a major …
Design, clinical translation and immunological response of biomaterials in regenerative medicine
The field of regenerative medicine aims to replace tissues lost as a consequence of disease,
trauma or congenital abnormalities. Biomaterials serve as scaffolds for regenerative …
trauma or congenital abnormalities. Biomaterials serve as scaffolds for regenerative …